(Q51367458)

English

Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study.

scientific article published in August 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Factors predicting therapeutic efficacy of combination treatment with sitagliptin and metformin in type 2 diabetic patients: the COSMETIC study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

Jee Hyun An

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hayley Shin

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ah Reum Khang

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Yenna Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hwa Young Ahn

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Ji Won Yoon

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Seon Mee Kang

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Young Min Cho

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Kyong Soo Park

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Hak Chul Jang

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 August 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Clinical Endocrinology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

77

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

215-223

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, compared with the sulfonylurea, glipizide, in patients with type 2 diabetes inadequately controlled on metformin alone: a randomized, double-blind, non-inferiority trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Efficacy and safety of sitagliptin monotherapy in Japanese patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Effect of adding sitagliptin, a dipeptidyl peptidase-4 inhibitor, to metformin on 24-h glycaemic control and beta-cell function in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Metformin effects on dipeptidylpeptidase IV degradation of glucagon-like peptide-1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Enhanced secretion of glucagon-like peptide 1 by biguanide compounds

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Effect of metformin on glucagon-like peptide 1 (GLP-1) and leptin levels in obese nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Effect of initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin on glycemic control in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Efficacy and safety of sitagliptin and metformin as initial combination therapy and as monotherapy over 2 years in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing pioglitazone therapy in patients with type 2 diabetes: a 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Predictive clinical parameters for the therapeutic efficacy of sitagliptin in korean type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Retrospective analysis on the efficacy, safety and treatment failure group of sitagliptin for mean 10-month duration

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Insulin Secretion in Response to Glycemic Stimulus: Relation of Delayed Initial Release to Carbohydrate intolerance in Mild Diabetes Mellitus*

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Body mass index and cardiovascular disease in the Asia-Pacific Region: an overview of 33 cohorts involving 310 000 participants

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

The effect of oral antidiabetic agents on A1C levels: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Robust improvements in fasting and prandial measures of beta-cell function with vildagliptin in drug-naïve patients: analysis of pooled vildagliptin monotherapy database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Effects of low intensity exercise therapy on early phase insulin secretion in overweight subjects with impaired glucose tolerance and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Biochemical and molecular mechanisms in the development of diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Oxidative stress and diabetic vascular complications

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Pancreatic B-cell function is altered by oxidative stress induced by acute hyperglycaemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Glucolipotoxicity and beta cells in type 2 diabetes mellitus: target for durable therapy?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-α in mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Continuous infusion of glucose with model assessment: measurement of insulin resistance and beta-cell function in man.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

The heritability of beta cell function parameters in a mixed meal test design

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Impaired beta-cell sensitivity to glucose and maximal insulin secretory capacity in adolescents with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Risk assessment by post-challenge plasma glucose, insulin response ratio, and other indices of insulin resistance and/or secretion for predicting the development of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Relationships between insulin secretion after intravenous and oral glucose administration in subjects with glucose tolerance ranging from normal to overt diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Impaired fasting glycaemia vs impaired glucose tolerance: similar impairment of pancreatic alpha and beta cell function but differential roles of incretin hormones and insulin action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Meal composition affects insulin secretion in women with type 2 diabetes: a comparison with healthy controls. The Hoorn prandial study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Assessment of beta-cell function during the oral glucose tolerance test by a minimal model of insulin secretion.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Inhibition of dipeptidyl peptidase IV activity by oral metformin in Type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Efficacy and safety of the dipeptidyl peptidase-4 inhibitor sitagliptin added to ongoing metformin therapy in patients with type 2 diabetes inadequately controlled with metformin alone.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Effect of Single Oral Doses of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, on Incretin and Plasma Glucose Levels after an Oral Glucose Tolerance Test in Patients with Type 2 Diabetes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2011.04240.X

21 January 2018

Identifiers

10.1111/J.1365-2265.2011.04240.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

release_qagqsxkvajfczbpwf2k5ixsaj4

1 reference

https://api.fatcat.wiki/v0/release/qagqsxkvajfczbpwf2k5ixsaj4

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21955147%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q51367458&oldid=1836810006"